相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel and effective inhibitor combination involving bortezomib and OTSSP167 for breast cancer cells in light of label-free proteomic analysis
Emrah Okur et al.
CELL BIOLOGY AND TOXICOLOGY (2019)
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial
Andrew D. Zelenetz et al.
BLOOD (2019)
Investigation of expressions of PDK1, PLK1 and c-Myc in diffuse large B-cell lymphoma
Yuhua Feng et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2019)
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma
Alexandre Chlenski et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Targeting the Bcl-2 Family in B Cell Lymphoma
Clare M. Adams et al.
FRONTIERS IN ONCOLOGY (2019)
EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions
Yujie Deng et al.
JOURNAL OF CANCER (2019)
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Stefanie Jilg et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
Arnold Bolomsky et al.
HAEMATOLOGICA (2018)
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
Arnold Bolomsky et al.
HAEMATOLOGICA (2018)
Identification of potential therapeutic targets in prostate cancer through a cross-species approach
Sarah Jurmeister et al.
EMBO MOLECULAR MEDICINE (2018)
Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia
Ya Zhang et al.
ONCOGENE (2018)
An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy
Vanessa Szablewski et al.
Oncotarget (2018)
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer
Juan Wang et al.
CANCER MEDICINE (2018)
Current and emerging treatment options for mantle cell lymphoma
Bita Fakhri et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2017)
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth
Ramakrishna Edupuganti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Lymphoma: turning biology into cures
T. Cummin et al.
CLINICAL MEDICINE (2016)
Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight
B. Barry Toure et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition
Laurel T. Bate-Eya et al.
ONCOTARGET (2016)
OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases
Wenbin Ji et al.
PLOS ONE (2016)
MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells
Lijs Beke et al.
BIOSCIENCE REPORTS (2015)
Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis
Karen Dybkaer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXMI-Dependent Manner
Sung-Hak Kim et al.
STEM CELL REPORTS (2015)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor
Yong-Soon Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia
Houda Alachkar et al.
ONCOTARGET (2014)
Maternal Embryonic Leucine Zipper Kinase (MELK): A Novel Regulator in Cell Cycle Control, Embryonic Development, and Cancer
Pengfei Jiang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
Kaushal Joshi et al.
STEM CELLS (2013)
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Zijun Y. Xu-Monette et al.
BLOOD (2012)
Overexpression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma
Shahab Uddin et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Molecular pathogenesis of mantle cell lymphoma
Pedro Jares et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression
Seungho Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
Teresa M. Cardesa-Salzmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
A framework for oligonucleotide microarray preprocessing
Benilton S. Carvalho et al.
BIOINFORMATICS (2010)
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms
Elke De Bruyne et al.
BLOOD (2010)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
Mark R. Pickard et al.
BREAST CANCER RESEARCH (2009)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas
Suely K. N. Marie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers
D Gray et al.
CANCER RESEARCH (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma
RM Amini et al.
LEUKEMIA & LYMPHOMA (2002)
Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation
N Davezac et al.
ONCOGENE (2002)
分享论文
